Viewing Study NCT01114750

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:13 PM
Ignite Modification Date: 2026-05-20 @ 2:32 AM
Study NCT ID: NCT01114750
Status: SUSPENDED
Last Update Posted: 2010-10-05
First Post: 2010-04-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)
Sponsor: Bows Pharmaceuticals AG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None blood glucose View
None blood insulin View
None dextran View
None diabetes View
None hyperglycemia View
None hypoglycemia View
None oral delivery View
None portal delivery View